EXICURE INC (XCUR) Stock News

NASDAQ:XCUR - Nasdaq - US30205M3097 - Common Stock - Currency: USD

7.8525 -0.31 (-3.77%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

XCUR Latest News, Press Relases and Analysis

All

Press Releases

25 days ago - By: Benzinga - Mentions: GOVX SNGX LIXT OGEN ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

25 days ago - By: Benzinga - Mentions: GNTA GOVX SNGX OGEN ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

a month ago - By: Exicure, Inc.

Exicure, Inc. Reports First Quarter 2025 Financial Results

2 months ago - By: Exicure, Inc.

Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q

3 months ago - By: Exicure, Inc.

Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant

3 months ago - By: Yahoo Finance - Mentions: TSLA NVDA AAPL

Why Exicure Inc. (XCUR) Soared on Monday

3 months ago - By: Exicure, Inc.

Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma

4 months ago - By: Exicure, Inc.

Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)

4 months ago - By: Exicure, Inc.

Exicure, Inc. Reports Full Year 2024 Financial Results

4 months ago - By: Exicure, Inc.

Exicure, Inc. (Nasdaq: XCUR) Announces Issuance of New Patent in Australia

6 months ago - By: Exicure, Inc.

CORRECTING and REPLACING Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.

7 months ago - By: Exicure, Inc.

Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech

7 months ago - By: Exicure, Inc.

CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes

8 months ago - By: Exicure, Inc.

Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results